Association between the polymorphisms in intercellular adhesion molecule-1 and the risk of coronary atherosclerosis: A case-controlled study

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Yang, Mao ^a   Fu, Zhenkun ^a   Zhang, Qingjiang ^c   Xin, Yu ^a   Chen, Yanjun ^a   Tian, Ye ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CELL ADHESION MOLECULE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID; ICAM1 PROTEIN, HUMAN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ALLELE; ANGIOGRAPHY; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; HYPERTENSION; ICAM 1 GENE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CORONARY ARTERY DISEASE; GENETICS; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS A; APOLIPOPROTEINS B; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HAPLOTYPES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRIGLYCERIDES;

EID: 84907932281     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109658     Document Type: Article

References (33)

1. Libby P (2013) Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 368: 2004-2013.
2. Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27: 2292-2301.
3. Moore KJ, Sheedy FJ, Fisher EA (2013) Macrophages in atherosclerosis: A dynamic balance. Nat Rev Immunol 13: 709-721.
4. Inwald D, Davies EG, Klein N (2001) Demystified...adhesion molecule deficiencies. Mol Pathol 54: 1-7.
5. Glass CK, Witztum JL (2001) Atherosclerosis. the road ahead. Cell 104: 503- 516.
6. Blankenberg S, Rupprecht HJ, Bickel, C Peetz D, Hafner G, et al. (2001) Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104: 1336-1342.
7. Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, et al. (2002) Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol 39: 1133-1138.
8. Giacconi R, Caruso C, Lio D, Muti E, Cipriano C, et al. (2007) CD14 C (-260)T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins. Int J Cardiol 120: 45-51.
9. Hulkkonen J, Lehtimäki T, Mononen N, Juonala M, Hutri-Kähönen N, et al. (2009) Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study. Atherosclerosis 203: 454-458.
10. Hernesniemi JA, Heikkilä A, Raitakari OT, Kähönen M, Juonala M, et al. (2010) Interleukin-18 gene polymorphism and markers of subclinical atherosclerosis. The Cardiovascular Risk in Young Finns Study. Ann Med 42: 223- 230.
11. Hoke M, Speidl W, Schillinger M, Minar E, Zehetmayer S, et al. (2012) Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis. Eur J Clin Invest 42: 921-926.
12. Zhang K, Zhang L, Zhou B, Wang Y, Song Y, et al. (2012) Lack of association between TLR4 Asp299Gly polymorphism and atherosclerosis: Evidence from meta-analysis. Thromb Res 130:e203-208.
13. Ji YN, Wang Q, Zhan P (2012) Intercellular adhesion molecule 1 gene K469E polymorphism is associated with coronary heart disease risk: A meta-analysis involving 12 studies. Mol Biol Rep 39: 6043-6048.
14. Volcik KA, Ballantyne CM, Hoogeveen R, Folsom AR, Boerwinkle E (2010) Intercellular adhesion molecule-1 G241R polymorphism predicts risk of incident ischemic stroke: Atherosclerosis Risk in Communities study. Stroke 41: 1038- 1040.
15. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, et al. (2001) ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 103: 3019-3041.
16. Ross R (1995) Growth regulatory mechanisms and formation of the lesions of atherosclerosis. Ann N Y Acad Sci 748: 1-4.
17. Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7: 77-86.
18. Blankenberg S, Barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170: 191-203.
19. Güray U, Erbay AR, Güray Y, Yilmaz MB, Boyaci AA, et al. (2004) Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol 96: 235-240.
20. Banks K, Puttagunta D, Murphy S, Lo M, McGuire DK, et al. (2011) Clinical characteristics, vascular function, and inflammation in women with angina in the absence ofcoronary atherosclerosis: The Dallas Heart Study. JACC Cardiovasc Imaging 4: 65-73.
21. Taylor AJ, Bindeman J, Le TP, Bauer K, Byrd C, et al. (2008) Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-media thickness. Atherosclerosis 197: 339-345.
22. Gu Y, Liu Z, Li L, Guo CY, Li CJ, et al. (2013) OLR1, PON1 and MTHFR gene polymorphisms, conventional risk factors and the severity ofcoronary atherosclerosis in a Chinese Han population. Cell Physiol Biochem 31: 143-152.
23. Boumil RM, Letts VA, Roberts MC, Lenz C, Mahaffey CL, et al. (2010) A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice. PLoS Genet 6:e1001046.
24. Baralle D, Baralle M (2005) Splicing in action: Assessing disease causing sequence changes. J Med Genet 42: 737-748.
25. Krauss V, Pecyna M, Kurz K, Sass H (2005) Phylogenetic mapping of intron positions: A case study of translation initiation factor eIF2gamma. Mol Biol Evol 22: 74-84.
26. Chen JM, Ferec C, Cooper DN (2006) A systematic analysis of diseaseassociated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet 120: 1-21.
27. Lytle JR, Yario TA, Steitz JA (2007) Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A 104: 9667-9672.
28. Giannoglou GD, Koskinas KC, Tziakas DN, Ziakas AG, Antoniadis AP, et al. (2009) Total cholesterol content of erythrocyte membranes and coronary atherosclerosis: An intravascular ultrasound pilot study. Angiology 60: 676-682.
29. Cui Y, Watson DJ, Girman CJ, Shapiro DR, Gotto AM, et al. (2009) Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). Am J Cardiol 104: 829-834.
30. Rifai N, Ma J, Sacks FM, Ridker PM, Hernandez WJ, et al. (2004) Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. Clin Chem 50: 1364-1371.
31. Gazzaruso C, Bruno R, Pujia A, De Amici E, Fratino P, et al. (2006) Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients. Int J Cardiol 108: 354-358.
32. Albers JJ, Slee A, O'Brien KD, Robinson JG, Kashyap ML, et al. (2013) Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: The AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes). J Am Coll Cardiol 62: 1575-1579.
33. Nicholls SJ, Tuzcu EM, Wolski K, Bayturan O, Lavoie A, et al. (2011) Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study. J Am Coll Cardiol 57: 153-159.